Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, June 28 '25)

Image
By G.M.

 


    Antiviral Res

  1. HUSSAIN S, Meijer A, Govorkova EA, Dapat C, et al
    Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020-2023.
    Antiviral Res. 2025 Jun 24:106217. doi: 10.1016/j.antiviral.2025.106217.
    PubMed         Abstract available


    Clin Infect Dis

  2. HARUN MGD, Sumon SA, Anwar MMU, Mohona TM, et al
    Infection Prevention and Control Knowledge, Attitudes, and Practices of Healthcare Workers in Tertiary Care Hospitals in Bangladesh During Coronavirus Disease 2019: A Multicenter Cross-sectional Survey.
    Clin Infect Dis. 2025 Jun 25:ciaf246. doi: 10.1093.
    PubMed         Abstract available

  3. DUONG KS, Henry SS, Duong TQ
    SARS-CoV-2 infection increases long-term risk of pneumonia in an urban population: an observational cohort study up to 46 months post-infection.
    Clin Infect Dis. 2025 Jun 25:ciaf345. doi: 10.1093.
    PubMed         Abstract available

  4. OPENSHAW JJ, Chen J, Rodriguez R, Gottlieb M, et al
    The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection on Long-Term Symptoms in the Innovative Support for Patients With SARS-CoV-2 Infections Registry (INSPIRE).
    Clin Infect Dis. 2025 Jun 18:ciaf225. doi: 10.1093.
    PubMed         Abstract available


    Emerg Infect Dis

  5. TARBUCK NN, Garushyants SK, McBride DS, Dennis PM, et al
    Persistence of SARS-CoV-2 Alpha Variant in White-Tailed Deer, Ohio, USA.
    Emerg Infect Dis. 2025;31:1319-1329.
    PubMed         Abstract available


    Infect Control Hosp Epidemiol

  6. WHITELEY TD, Stimson J, Brown CS, Robotham JV, et al
    Modeling the impact of health care worker masking to reduce nosocomial SARS-CoV-2 transmission under varying adherence, prevalence, and transmission settings.
    Infect Control Hosp Epidemiol. 2025 Jun 27:1-7. doi: 10.1017/ice.2025.
    PubMed         Abstract available


    Int J Infect Dis

  7. CHAPMAN A, Barouch DH, Lip GYH, Pliakas T, et al
    Risk of severe outcomes from COVID-19 in comorbid populations in the Omicron era: a systematic review and meta-analysis.
    Int J Infect Dis. 2025 Jun 24:107958. doi: 10.1016/j.ijid.2025.107958.
    PubMed         Abstract available

  8. PAUL E, Brown GW, Dechamps M, Kalk A, et al
    Corrigendum to "COVID-19: an 'extraterrestrial' disease?", [International Journal of Infectious Diseases, Volume 110, 155-159, September 2021].
    Int J Infect Dis. 2025;158:107951.
    PubMed        

  9. TEODORO LI, Ovsyannikova IG, Grill DE, Poland GA, et al
    Seroprevalence of RSV Antibodies in a Contemporary (2022 - 2023) Cohort of Adults.
    Int J Infect Dis. 2025 Jun 21:107964. doi: 10.1016/j.ijid.2025.107964.
    PubMed         Abstract available

  10. JOSEPH JT, Grau-Sepulveda M, Griffith BC, Lufes N, et al
    Evaluating the introduction of COVID-19 oral antivirals through a test and treat program: outcomes from a cohort study in four African countries.
    Int J Infect Dis. 2025 Jun 19:107956. doi: 10.1016/j.ijid.2025.107956.
    PubMed         Abstract available

  11. TSUCHIHASHI Y, Tamura K, Matsumoto K, Mitsushima S, et al
    Comparative analysis of streptococcal toxic shock syndrome caused by three beta-hemolytic streptococcal species in Japan.
    Int J Infect Dis. 2025 Jun 18:107962. doi: 10.1016/j.ijid.2025.107962.
    PubMed         Abstract available

  12. ESTILL J, Belayneh EG, Beale S, Keiser O, et al
    Estimation of the number of people affected by post COVID-19 condition in Switzerland in 2023: A mathematical model.
    Int J Infect Dis. 2025 Jun 18:107963. doi: 10.1016/j.ijid.2025.107963.
    PubMed         Abstract available


    J Med Virol

  13. SANCHEZ-SIMARRO A, Carretero D, Grau B, Martinez-Perez M, et al
    Neutralizing Antibody and T-Cell Spike Targeted Responses Following Receipt of a Monovalent Omicron JN.1-Adapted mRNA COVID-19 Vaccine in Immunosuppressed and Healthy Individuals.
    J Med Virol. 2025;97:e70463.
    PubMed         Abstract available

  14. WANG Y, Sun H, Liu Y, Song Y, et al
    TMEM106B Supports Viral Entry and Syncytia Formation Mediated by the Spike Proteins From Omicron BA.2.86 and JN.1.
    J Med Virol. 2025;97:e70439.
    PubMed         Abstract available

  15. BARY F, Karunananda MV, Jeewandara C, Danasekara S, et al
    Changes in Population Immunity to Omicron SARS-CoV-2 Variants and Selected Sarbecoviruses From 2020 to 2023 in Urban Colombo, Sri Lanka.
    J Med Virol. 2025;97:e70462.
    PubMed         Abstract available


    JAMA

  16. GRUNEBAUM A, Chervenak FA
    Professional Responsibility for COVID-19 Vaccination in Pregnancy.
    JAMA. 2025 Jun 25. doi: 10.1001/jama.2025.11328.
    PubMed        


    Lancet


  17. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Jun 24:S0140-6736(25)01037-2. doi: 10.1016/S0140-6736(25)01037.
    PubMed         Abstract available

  18. PAIL O, Lin MJ, Anagnostou T, Brown BD, et al
    Cancer vaccines and the future of immunotherapy.
    Lancet. 2025 Jun 17:S0140-6736(25)00553-7. doi: 10.1016/S0140-6736(25)00553.
    PubMed         Abstract available


    Lancet Infect Dis

  19. LIU JW, Lai CC, Hsueh PR
    Resurgence of human metapneumovirus in the post-COVID-19 era: pathogenesis, epidemiological shifts, clinical impact, and future challenges.
    Lancet Infect Dis. 2025 Jun 20:S1473-3099(25)00240.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  20. DIAZ MH, Hersh AL, Olson J, Shah SS, et al
    Mycoplasma pneumoniae Infections in Hospitalized Children - United States, 2018-2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:394-400.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

Stability of #influenza viruses in the #milk of #cows and #sheep

By G.M.
Abstract In late 2023, H5N1 high pathogenicity avian influenza (HPAIV) started circulating in dairy cattle in the USA . High viral titres were detected in milk from infected cows , raising concerns about onwards human infections . Although pasteurisation was shown to effectively inactivate influenza viruses in milk, unpasteurised milk still poses a risk of infection, both from occupational exposure in dairies and from the consumption of raw milk. We therefore assessed how long influenza viruses could remain infectious for in milk without heat inactivation. We examined the stability of a panel of influenza viruses in milk , including a contemporary H5N1 HPAIV and a variety of other influenza A and D viruses. We incubated viruses in cows' milk under laboratory conditions : at room temperature to simulate exposure in dairies and at 4°C to simulate exposure to refrigerated raw milk. Following an isolated report of H5N1 viral RNA being detected in milk from a sheep in the UK , we also c...
Post a Comment
Read more »

#Evidence of #Viremia in Dairy #Cows Naturally Infected with #Influenza A {#H5N1} Virus, #California, #USA

By G.M.
Abstract We confirmed influenza A virus (IAV) by PCR in serum from 18 cows on 3 affected dairy farms in California, USA . Our findings indicate the presence of viremia and might help explain IAV transmission dynamics and shedding patterns in cows. An understanding of those dynamics could enable development of IAV mitigation strategies. Source: US Centers for Disease Control and Prevention,  https://wwwnc.cdc.gov/eid/article/31/7/25-0134_article ____
Post a Comment
Read more »